Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies
Abstract Introduction A rapid transition from a clinical‐based classification to a pathology‐based classification of neurodegenerative conditions, largely promoted by the increasing availability of imaging biomarkers, is emerging. The Framework for Innovative Multi‐tracer molecular Brain Imaging, fu...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-12-01
|
Series: | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
Subjects: | |
Online Access: | https://doi.org/10.1016/j.dadm.2019.02.004 |
id |
doaj-50bd95b6267e48ed9f70a0858de39d47 |
---|---|
record_format |
Article |
spelling |
doaj-50bd95b6267e48ed9f70a0858de39d472020-11-25T03:43:18ZengWileyAlzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring2352-87292019-12-0111132733210.1016/j.dadm.2019.02.004Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathiesDaniela Perani0Leonardo Iaccarino1Andreas H. Jacobs2IMBI Brain Imaging Working GroupAdriaan A. Lammertsma3Agneta Nordberg4Albert D. Windhorst5Alexander Gerhard6Alexandra Winkeler7Andreas H. Jacobs8Anthony Gee9Bertrand Kuhnast10Christer Halldin11Daniela Perani12David Brooks13Elena Rodriguez‐Vieitez14Federico E. Turkheimer15Francisco López‐Picón16Gitte M. Knudsen17Johnny Vercouillie18Juha O. Rinne19Karl Herholz20Koen Van Laere21Andrea Varrone22Marie Joao Santiago‐Ribeiro23Matthias M. Herth24Michael A. Carroll25Sylvie Chalon26Michel Bottlaender27Oskar Hansson28Paul Edison29Rainer Hinz30Ronald Boellaard31Rosa Maria Moresco32Sabina Pappata33Vita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyEuropean Institute for Molecular Imaging, University of MünsterMünsterGermanyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyVita‐Salute San Raffaele UniversityMilanItalyAbstract Introduction A rapid transition from a clinical‐based classification to a pathology‐based classification of neurodegenerative conditions, largely promoted by the increasing availability of imaging biomarkers, is emerging. The Framework for Innovative Multi‐tracer molecular Brain Imaging, funded by the EU Joint Program ‐ Neurodegenerative Disease Research 2016 “Working Groups for Harmonisation and Alignment in Brain Imaging Methods for Neurodegeneration,” aimed at providing a roadmap for the applications of established and new molecular imaging techniques in dementia. Methods We consider current and future implications of adopting a pathology‐based framework for the use and development of positron emission tomography techniques. Results This approach will enhance efforts to understand the multifactorial etiology of Alzheimer's disease and other dementias. Discussion The availability of pathology biomarkers will soon transform clinical and research practice. Crucially, a comprehensive understanding of strengths and caveats of these techniques will promote an informed use to take full advantage of these tools.https://doi.org/10.1016/j.dadm.2019.02.004PET molecular imagingRadiotracersProtheinopathiesAmyloidTauNeuroinflammation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Daniela Perani Leonardo Iaccarino Andreas H. Jacobs IMBI Brain Imaging Working Group Adriaan A. Lammertsma Agneta Nordberg Albert D. Windhorst Alexander Gerhard Alexandra Winkeler Andreas H. Jacobs Anthony Gee Bertrand Kuhnast Christer Halldin Daniela Perani David Brooks Elena Rodriguez‐Vieitez Federico E. Turkheimer Francisco López‐Picón Gitte M. Knudsen Johnny Vercouillie Juha O. Rinne Karl Herholz Koen Van Laere Andrea Varrone Marie Joao Santiago‐Ribeiro Matthias M. Herth Michael A. Carroll Sylvie Chalon Michel Bottlaender Oskar Hansson Paul Edison Rainer Hinz Ronald Boellaard Rosa Maria Moresco Sabina Pappata |
spellingShingle |
Daniela Perani Leonardo Iaccarino Andreas H. Jacobs IMBI Brain Imaging Working Group Adriaan A. Lammertsma Agneta Nordberg Albert D. Windhorst Alexander Gerhard Alexandra Winkeler Andreas H. Jacobs Anthony Gee Bertrand Kuhnast Christer Halldin Daniela Perani David Brooks Elena Rodriguez‐Vieitez Federico E. Turkheimer Francisco López‐Picón Gitte M. Knudsen Johnny Vercouillie Juha O. Rinne Karl Herholz Koen Van Laere Andrea Varrone Marie Joao Santiago‐Ribeiro Matthias M. Herth Michael A. Carroll Sylvie Chalon Michel Bottlaender Oskar Hansson Paul Edison Rainer Hinz Ronald Boellaard Rosa Maria Moresco Sabina Pappata Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring PET molecular imaging Radiotracers Protheinopathies Amyloid Tau Neuroinflammation |
author_facet |
Daniela Perani Leonardo Iaccarino Andreas H. Jacobs IMBI Brain Imaging Working Group Adriaan A. Lammertsma Agneta Nordberg Albert D. Windhorst Alexander Gerhard Alexandra Winkeler Andreas H. Jacobs Anthony Gee Bertrand Kuhnast Christer Halldin Daniela Perani David Brooks Elena Rodriguez‐Vieitez Federico E. Turkheimer Francisco López‐Picón Gitte M. Knudsen Johnny Vercouillie Juha O. Rinne Karl Herholz Koen Van Laere Andrea Varrone Marie Joao Santiago‐Ribeiro Matthias M. Herth Michael A. Carroll Sylvie Chalon Michel Bottlaender Oskar Hansson Paul Edison Rainer Hinz Ronald Boellaard Rosa Maria Moresco Sabina Pappata |
author_sort |
Daniela Perani |
title |
Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies |
title_short |
Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies |
title_full |
Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies |
title_fullStr |
Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies |
title_full_unstemmed |
Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies |
title_sort |
application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies |
publisher |
Wiley |
series |
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
issn |
2352-8729 |
publishDate |
2019-12-01 |
description |
Abstract Introduction A rapid transition from a clinical‐based classification to a pathology‐based classification of neurodegenerative conditions, largely promoted by the increasing availability of imaging biomarkers, is emerging. The Framework for Innovative Multi‐tracer molecular Brain Imaging, funded by the EU Joint Program ‐ Neurodegenerative Disease Research 2016 “Working Groups for Harmonisation and Alignment in Brain Imaging Methods for Neurodegeneration,” aimed at providing a roadmap for the applications of established and new molecular imaging techniques in dementia. Methods We consider current and future implications of adopting a pathology‐based framework for the use and development of positron emission tomography techniques. Results This approach will enhance efforts to understand the multifactorial etiology of Alzheimer's disease and other dementias. Discussion The availability of pathology biomarkers will soon transform clinical and research practice. Crucially, a comprehensive understanding of strengths and caveats of these techniques will promote an informed use to take full advantage of these tools. |
topic |
PET molecular imaging Radiotracers Protheinopathies Amyloid Tau Neuroinflammation |
url |
https://doi.org/10.1016/j.dadm.2019.02.004 |
work_keys_str_mv |
AT danielaperani applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT leonardoiaccarino applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT andreashjacobs applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT imbibrainimagingworkinggroup applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT adriaanalammertsma applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT agnetanordberg applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT albertdwindhorst applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT alexandergerhard applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT alexandrawinkeler applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT andreashjacobs applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT anthonygee applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT bertrandkuhnast applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT christerhalldin applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT danielaperani applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT davidbrooks applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT elenarodriguezvieitez applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT federicoeturkheimer applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT franciscolopezpicon applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT gittemknudsen applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT johnnyvercouillie applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT juhaorinne applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT karlherholz applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT koenvanlaere applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT andreavarrone applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT mariejoaosantiagoribeiro applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT matthiasmherth applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT michaelacarroll applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT sylviechalon applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT michelbottlaender applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT oskarhansson applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT pauledison applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT rainerhinz applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT ronaldboellaard applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT rosamariamoresco applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies AT sabinapappata applicationofadvancedbrainpositronemissiontomographybasedmolecularimagingforabiologicalframeworkinneurodegenerativeproteinopathies |
_version_ |
1724520768377716736 |